MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Home・Aandelen Lijst・Avita Therapeutics Inc

Avita Therapeutics Inc

Gesloten

3.43 -2

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.37

Max

3.5

Belangrijke statistieken
By Trading Economics
Inkomsten	-3.3M -13M
Verkoop	-1.4M 17M
Winstmarge	-77.289
Werknemers	260
EBITDA	-3.2M -11M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+20.74% upside

Dividenden
By Dow Jones
Volgende Winsten	12 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-15M 106M
Vorige openingsprijs	5.43
Vorige sluitingsprijs	3.43

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

8.83 / 9.77 Steun & Weerstand

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 jan 2026, 18:44 UTC

Belangrijke Marktbewegers

Agenus Falls After $141 Million Zydus Deal Closes

15 jan 2026, 17:51 UTC

Belangrijke Marktbewegers

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15 jan 2026, 17:25 UTC

Belangrijke Marktbewegers

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15 jan 2026, 23:48 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

15 jan 2026, 23:48 UTC

Marktinformatie

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15 jan 2026, 23:40 UTC

Marktinformatie

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15 jan 2026, 23:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

15 jan 2026, 23:11 UTC

Marktinformatie

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15 jan 2026, 23:01 UTC

Marktinformatie

New Zealand's Economy Enters An Upswing -- Market Talk

15 jan 2026, 22:56 UTC

Marktinformatie

Winsten

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15 jan 2026, 22:51 UTC

Marktinformatie

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15 jan 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15 jan 2026, 21:50 UTC

Marktinformatie

Winsten

Financial Services Roundup: Market Talk

15 jan 2026, 21:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Energy & Utilities Roundup: Market Talk

15 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

15 jan 2026, 21:27 UTC

Winsten

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15 jan 2026, 21:15 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Global Commodities Roundup: Market Talk

15 jan 2026, 21:11 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

15 jan 2026, 21:11 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15 jan 2026, 20:10 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15 jan 2026, 20:04 UTC

Winsten

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15 jan 2026, 20:03 UTC

Marktinformatie

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15 jan 2026, 19:26 UTC

Marktinformatie

Silver Closes at Fresh High -- Market Talk

15 jan 2026, 18:29 UTC

Belangrijke Marktbewegers

Agenus Falls After $141M Zydus Deal Closes

15 jan 2026, 18:20 UTC

Winsten

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15 jan 2026, 17:56 UTC

Marktinformatie

Winsten

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15 jan 2026, 17:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Auto & Transport Roundup: Market Talk

15 jan 2026, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

15 jan 2026, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

15 jan 2026, 17:02 UTC

Acquisities, Fusies, Overnames

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

20.74% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.25 USD 20.74%

Hoogste 5.5 USD

Laagste 3 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Avita Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.